Lesaffre Strengthens its Research, Development & Innovation (RD&I) with the Acquisition of Altar, a Company Owned by Ginkgo Bioworks

October 17, 2024 Lesaffre

Lesaffre, a key global player in the field of fermentation and microorganisms, announces the acquisition of Altar, a French start-up specializing in Adaptive Laboratory Evolution (ALE). Created in 2017, Altar will complement Lesaffre’s existing know-how and technologies to boost the Group’s capacity of innovation in fermentation and microorganisms.

Lesaffre Acquires a Majority Stake in Biorigin to Strengthen and Broaden its Savory Ingredients Offering

October 7, 2024 Lesaffre

The aim of this deal is to leverage Lesaffre’s and Biorigin’s complementary capabilities to enable enhanced yeast derivative and savory ingredient solutions for customers worldwide. The business combination between Lesaffre and Biorigin will offer customers benefits by upgrading production capacity and new solutions based on the production and marketing of naturally derived ingredients for human food and animal nutrition industries.

Lesaffre Reinforces its Presence in Savory Ingredients Market by Acquiring DSM-Firmenich’s Yeast Extract Business

June 12, 2024 Lesaffre

Lesaffre and dsm-firmenich have reached agreement for a multi-part collaboration in yeast derivatives serving the savory ingredients space. Lesaffre will acquire dsm firmenich’s yeast extract go-to-market organization and know-how, enabling production of dsm-firmenich’s yeast extract products in Lesaffre’s global manufacturing network.

Lesaffre Strengthens its Presence in the United States

November 17, 2023 Lesaffre

Lesaffre, a key global player in fermentation and microorganisms, announces a series of investments in the U.S. to strengthen its geographical footprint in the region, respond to growth in nutrition and health, and better serve its customers.

Lesaffre supports Gut Microbiota for Health, a platform created by European Society of Neurogastroenterology and Motility

May 23, 2022 Lesaffre

Lesaffre becomes gold sponsor of Gut Microbiota For Health (GMFH), a platform created by the Gut Microbiota and Health section of the European Society of Neurogastroenterology and Motility (ESNM). The aim of this platform is to provide information, foster research, training and dissemination of knowledge of the role of the gut microbiota in intestinal and non-intestinal health and disease, prevention and therapeutic, and extended to probiotics.